The FDA has approved Ozempic for type 2 diabetes, but it’s also known for its use off-label for weightloss. The agency has authorized NovoNordisk’s Wegovy—which shares the same active ...
What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.
Results that may be inaccessible to you are currently showing.